Company Profile
The United Laboratories International Holdings Limited, an investment holding company provides the research and development, manufacture, distribution, and sale of pharmaceutical products.
Its business is organized into three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products. Its portfolio also includes insulin series, antibiotics, and ophthalmic products, and veterinary drugs, as well as 6-aminopenicillanic acid and penicillin G potassium products. Additionally, it provides endocrine and metabolism, anti-infection, and human-used finished products, including ophthalmic drugs, topical dermatological drugs, etc.
Health and wellness products, such as general dietary supplements, healthcare food products, cross-border nutritional supplements, and medical and aesthetic skincare products for various categories comprising bone and joint nutrition, intestinal regulation, cardiovascular health, vision protection, and immunity enhancement.
It also is involved in the R&D, production, sale, and technical services of economic and companion animal medicines for livestock, poultry, and aquatic products and pets. The company has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and globally. Founded in 1990, The United Laboratories International is headquartered in Yuen Long, Hong Kong.